Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]

Non-randomised clinical trial aims to describe the safety and efficacy of...

Dr Richard Schilsky - University of Chicago, Chicago, USA

Non-randomised clinical trial aims to describe the safety and efficacy of commercially available, targeted anticancer drugs ( Dr Richard Schilsky - University of Chicago, Chicago, USA )

Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia...

Dr William Slayton - University of Florida, Gainsville, USA

Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia chromosome positive ALL ( Dr William Slayton - University of Florida, Gainsville, USA )

Raloxifene retained approximately 81% of the effectiveness of tamoxifen in...

Dr Lawrence Wickerham - NRG Oncology Research Group, Pittsburgh, USA

Raloxifene retained approximately 81% of the effectiveness of tamoxifen in preventing invasive breast cancer ( Dr Lawrence Wickerham - NRG Oncology Research Group, Pittsburgh, USA )

Next generation inhibitors help overcome problems of resistance in ALK positive...

Dr Ross Camidge - University of Colorado, Denver, USA

Next generation inhibitors help overcome problems of resistance in ALK positive lung cancer ( Dr Ross Camidge - University of Colorado, Denver, USA )

Transarterial chemoembolization with or without sorafenib for intermediate...

Prof Guohong Han - Xijing Hospital, Fourth Military Medical University, Xi'an...

Transarterial chemoembolization with or without sorafenib for intermediate-stage hepatocellular carcinoma ( Prof Guohong Han - Xijing Hospital, Fourth Military Medical University, Xi'an, China )

Phase III study finds initial nivolumab-based treatment halts melanoma...

Dr Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA

Phase III study finds initial nivolumab-based treatment halts melanoma progression ( Dr Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )

New targeted treatments for blood cancers: Multiple myeloma, non-Hodgkin...

Dr Merry-Jennifer Markham - University of Florida, Florida, USA

New targeted treatments for blood cancers: Multiple myeloma, non-Hodgkin lymphoma, genomic marker mismatch repair and myelofibrosis ( Dr Merry-Jennifer Markham - University of Florida, Florida, USA )

Targeted drug daratumumab shows promise in heavily treatment-resistant multiple...

Dr Saad Zafar Usmani - Levine Cancer Institute, Charlotte, USA

Targeted drug daratumumab shows promise in heavily treatment-resistant multiple myeloma ( Dr Saad Zafar Usmani - Levine Cancer Institute, Charlotte, USA )

Ibrutinib combination regimen shows substantial benefits in relapsed CLL

Dr Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA

Ibrutinib combination regimen shows substantial benefits in relapsed CLL ( Dr Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA )

Novel targeted drug palbociclib slows progression of hormone receptor-positive...

Dr Nicholas Turner - The Institute of Cancer Research, London, UK

Novel targeted drug palbociclib slows progression of hormone receptor-positive breast cancer ( Dr Nicholas Turner - The Institute of Cancer Research, London, UK )

Anastrozole offers higher breast cancer-free survival rates than tamoxifen...

Prof Richard Margolese - The Jewish General Hospital, McGill University...

Anastrozole offers higher breast cancer-free survival rates than tamoxifen following DCIS ( Prof Richard Margolese - The Jewish General Hospital, McGill University, Montreal, Canada )

Effective adjuvant chemotherapy for high-risk, localised prostate cancer

Prof Howard Sandler - Cedars Sinai Medical Center, Los Angeles, USA

Effective adjuvant chemotherapy for high-risk, localised prostate cancer ( Prof Howard Sandler - Cedars Sinai Medical Center, Los Angeles, USA )

More from ecancer